<DOC>
	<DOCNO>NCT02954757</DOCNO>
	<brief_summary>Uterine adenomyosis common uterine benign condition . They cause abnormal menstrual bleeding , menstrual pain . Although surgical intervention definitive treatment , woman prefer uterus preserve . High-intensity focus ultrasound ( HIFU ) therapy receive increase interest management uterine adenomyosis induce focal thermocoagulation fibroid . Results obtain various research group show HIFU treatment safe , effective highly acceptable patient . The main objective study evaluate therapeutic efficacy HIFU treatment uterine adenomyosis . In proposed study , 10 patient symptomatic uterine adenomyosis meet study inclusion criterion invite participate study involve use HIFU management adenomyosis . Background information patient age , body mass index , hormonal ( pre- postmenopausal ) status presence chronic medical disease collect . Subjects also ask complete eight-item section Uterine Fibroid Symptom Quality Of Life Questionnaire ( UFS-QOL ) menstrual pain score evaluate effect adenomyosis quality life woman .</brief_summary>
	<brief_title>High-intensity Focused Ultrasound Treatment Uterine Adenomyosis</brief_title>
	<detailed_description />
	<mesh_term>Adenomyosis</mesh_term>
	<criteria>Age &gt; 40 year old , future childbearing plan Age &gt; 30 year old , tubal sterilization Significant symptom related adenomyosis , intractable standard medical therapy , patient consider radiological intervention ( uterine fibroid embolization ) surgery . Clinical uterine size le 20 week gestation Localized adenomyotic lesion adenomyoma identify less 10 cm diameter judge contrast MRI , involve anterior posterior uterine wall . No laparotomy scar . Women able give consent . Other pelvic uncontrolled systemic disease Confirmed suspect pregnancy Patients unable communicate researcher treatment Patients contraindicate MRI examination Patients thick abdominal wall ( &gt; 5 cm , measure MRI ) Presence history acute pelvic inflammatory disease pelvic malignancy History low abdominal surgery , know severe pelvic endometriosis and/ extensive pelvic adhesion Presence significant size fibroid may interfere treatment affect outcome measure</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>uterine adenomyosis</keyword>
</DOC>